Covalent Drug Discovery Summit – December 12-14, Boston, MA

R&D

Are you looking to meet with all the key decision makers in the covalent space, including CXOs, VPs and Directors of Medicinal, Discovery, and Biological Chemistry?

Providing a dedicated platform for covalency specialists for the very first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December to unite 80+ covalent drug developers, small molecule experts, and key opinion leaders from academia.

Download the brochure: https://ter.li/6dv5ev

The agenda has been carefully curated alongside 20+ covalency experts from the likes of Totus Medicines, Scorpion Therapeutics, Covant Therapeutics, Novartis, Biogen and more to provide you with the perfect opportunity to assess the field, take back actionable insights to your team, and realize the potential of covalent drugs.